EI
PTCT icon

Ellevest Inc’s PTC Therapeutics PTCT Stock Holding History

Ellevest Inc’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 1942
2022
Q3 		$0 Buy
+1
New +$49 ﹤0.01% 1805
2022
Q2 		– Sell
-11
Closed – – 1626
2022
Q1 		$0 Sell
11
-148
-93% -$5.7K ﹤0.01% 1593
2021
Q4 		$6K Buy
159
+1
+0.6% +$38 ﹤0.01% 964
2021
Q3 		$6K Buy
158
+119
+305% +$4.89K ﹤0.01% 932
2021
Q2 		$2K Sell
39
-809
-95% -$34.7K ﹤0.01% 1058
2021
Q1 		$40K Buy
848
+706
+497% +$41.9K ﹤0.01% 521
2020
Q4 		$9K Buy
142
+66
+87% +$3.89K ﹤0.01% 758
2020
Q3 		$4K Buy
76
+36
+90% +$1.77K ﹤0.01% 811
2020
Q2 		$2K Buy
40
+11
+38% +$540 ﹤0.01% 906
2020
Q1 		$1K Buy
29
+9
+45% +$453 ﹤0.01% 954
2019
Q4 		$1K Buy
+20
New +$850 ﹤0.01% 848

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ellevest Inc's PTCT Position: Q4 2022 in Review

Ellevest Inc sold out of PTC Therapeutics (PTCT) in Q4 2022, closing a stake of 1 share.

Ellevest Inc first reported a position in PTCT in Q4 2019 and held it in 11 quarters. The position peaked at $40K in Q1 2021. 202 funds tracked by Wall St. Rank hold PTCT as of Q4 2022.

  • Ellevest Inc reported no remaining PTC Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Ellevest Inc sold 1 PTC Therapeutics share in Q4 2022.
  • Ellevest Inc first reported a position in PTC Therapeutics in Q4 2019 and held it in 11 quarters.
  • Ellevest Inc's PTC Therapeutics position peaked at $40K in Q1 2021.
  • 202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.